Diagnostic Accuracy of D-Dimer Testing and the Revised Geneva Score in the Prediction of Pulmonary Embolism
Received 3 November 2020
Accepted for publication 27 November 2020
Published 15 December 2020 Volume 2020:13 Pages 1537—1543
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Mostafa A Abolfotouh,1– 3 Khaled Almadani,3 Mohammed A Al Rowaily2,3
1King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; 2King Saud Bin-Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 3King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia
Correspondence: Mostafa A Abolfotouh
Research Center (Mail Code 3533), King Saud Bin-Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, National Guard Health Affairs, POB 22490, Riyadh 11426, Saudi Arabia
Email [email protected]
Background: Pulmonary embolism (PE) diagnosis can sometimes be challenging due to the disease having nonspecific signs and symptoms at the time of presentation. The present study aimed to evaluate the validity of the D-dimer in combination with the revised Geneva score (RGS) in the prediction of pulmonary embolism.
Patients and Methods: This is a retrospective study of 2010 patients with suspected PE who had undergone both D-dimer testing followed by chest CT angiography (CTPA), irrespective of the D-dimer test results, at King Abdulaziz Medical City, Riyadh, Saudi Arabia, over 3 years, from Jan. 2016 to Jan. 2019. The predictive accuracy of D-dimer, adjusted D-dimer, and RGS was calculated. The receiver operating characteristic “ROC” curve was applied to allocate the optimum RGS cutoff for PE prediction.
Results: The overall prevalence of PE was 16%. It was 0%, 25.8%, and 88.9% in low, intermediate, and high clinical probability categories of RGS, respectively. Both conventional and age-adjusted D-dimer thresholds showed significant level of agreement (kappa=0.81, p< 0.001), high sensitivity (94% and 92.8%), high negative predictive value “NPV” (91.2% and 91.4%), low specificity (12.3% and 15.3%), and low positive predictive value “PPV” (17.5% and 17.8%), respectively. Combination of the age-adjusted D-dimer threshold and RGS at a cut-off of 5 points would provide 100% sensitivity and 61.7% specificity 34.1% PPV, 100% NPV, and 0.87 area under the curve “AUC”. At an RGS cutoff < 5 points, PE could have been ruled out in more than one-half (1036, 51.5%) of all suspected cases, and would have saved the cost of CTPA.
Conclusion: Conventional and age-adjusted D-dimer tests showed high levels of agreement in the prediction of PE, high sensitivity, and low specificity. RGS has a good performance in PE prediction. Using the revised Geneva score alone rules out PE for more than one-half of all suspected without further imaging.
Keywords: validity, sensitivity, specificity, deep vein thrombosis, agreement, clinical probability, D-dimer, age-adjusted threshold, CTPA
Pulmonary embolism (PE) is a disease that is commonly encountered in the emergency department.1–3 The incidence of PE is estimated to be 60–70 per 100,000 general population.4 In Saudi Arabia, the incidence of Venous Thromboembolism (VTE) comprised of PE and Deep Vein Thrombosis (DVT) is estimated to be approximately 100 per 100,000 per year, with an estimated number of 25,000 patients per year.2 Its diagnosis can sometimes be challenging due to the disease having nonspecific signs and symptoms at the time of presentation.5 The diagnosis can be made clinically using some validated risk assessment tools such as the Revised Geneva Score6 and the Wells score7 based on the signs and symptoms of the patient. After that, the next step would be obtaining a serum D-dimer level from the patient.8 A negative result would rule out the possibility of having PE and would subsequently eliminate the need to use further confirmation by chest CT angiography (CTAP).
D-dimer levels are affected by age9,10 and many other variables such as malignancies and sepsis.9 This usually leads to unnecessary exposure to radiation while undergoing CTPA with studies showing that only 20% of those show positive results.11 The overuse of CTPA12 has been discussed in studies before highlighting that it has many disadvantages such as its effect on the patients. A study has shown that a single CTPA was associated with an average lifetime risk for cancer of 57/100,000 for females aged 17–19 years to 8/100,000 for males and females aged 80–89 years.13 Furthermore, the use of CPTA holds up the efficacy and the flow of the ER by taking up beds for an unnecessary amount of time.
Many studies have concluded that the use of the age-adjusted D-dimer level in patients >50 years old with low to moderate clinical probability to develop PE is safe and reduces the need to use unnecessary CTPA.14–16 The use of age-adjusted D-dimer cutoff value (patient’s age x 10 μg/L). It has been shown that patients (42%) aged more than 50 years old with low clinical probability had PE excluded in comparison with patients (36%) when fixed D-dimer cutoff value (500 μg/L) was applied.13 A case report with a patient older than 50 years who had an age-adjusted d-dimer level below the threshold and tested positive for PE, later on, has raised a point regarding the possibility of a false-negative result.17 One research compared the age-adjusted D-dimer level with a Clinical Probability Adjusted D-dimer level (1000 μg/L for low probability and 500 μg/L if intermediate), with a conclusion that the age-adjusted test is the preferred choice since it had a better Negative predictive value.18
No available guidelines are yet available at KAMC for the management of patients with suspected PE, and every suspected patient is subjected to both D-Dimer testing followed by CTPA, without waiting for the D-Dimer results that would take 4 to 5 h to be released, and this would lead to unnecessary exposure of patients to radiation. Thus, the aims of this study were (1) to compare the diagnostic accuracy of conventional D-dimer level with that of the age-adjusted D-dimer level, (2) to determine the diagnostic accuracy of using the age-adjusted D-dimer level, in combination with the revised Geneva score, for prediction and/or exclusion of PE, and (3) to estimate the amount of unnecessary exposure of patients to radiation, in adults who underwent CTPA in the past 3 years in King Abdulaziz Medical City, Riyadh, Saudi Arabia. The results of this study would help in writing the policy and procedures of management of patients with suspected PE in our health facility.
Patients and Methods
This is a retrospective study of 2010 patients with suspected PE (Those presenting with symptoms suggestive of PE including, physical exam, vital signs, and risk factors) who had undergone both D-dimer testing followed by chest CT angiography (CTPA) over 3 years, from January 2016 to January 2019. Patients who underwent CT angiography with no D-dimer test results were excluded from the study. Patients’ charts from hospital records (Best-Care) were reviewed and information was extracted using a data collection sheet. The study was conducted at the Emergency Care Center (ECC), King Abdulaziz Medical City (KAMC) in the central region of Saudi Arabia. KAMC is the largest health institution of the Ministry of National Guard Health Affairs (MNG-HA). MNG-HA provides healthcare services to national guard service members and their dependents through large medical cities located in the three most densely populated regions of KSA, namely the Central, Western, and Eastern regions. All facilities have been Joint Commission International (JCI) accredited since 2006.
ECC provides services for a rapidly growing patient population in all of its catchment areas, and it is considered the largest emergency care in Riyadh with a capacity of 125 beds and an ability to be increased if needed. The center has been established to provide urgent care services for all patients mainly trauma and critical medical cases. The center contains trauma X-Ray and Stat Lab to be ready when time becomes critical. It is divided into two main sections; Adult care (30 consultants and 34 Staff Physicians) and Pediatric care (20 consultants and 21 Staff Physicians). The average number of ECC visits is about 700 patients per day with some seasonal variations. Access to emergency services is determined by a process of ED triage. At triage, nurses assign an urgency rating according to observable physiological parameters.15 ECC follows the Canadian ED Triage and Acuity Scale (CTAS) guidelines in categorizing cases, based on the severity of the cases.
All patients, Saudis, and non-Saudis, ages 18 years or more, of both sexes were included. The following data were collected: Gender, D-dimer level, Result of the Chest CT Angiography, and elements of the Revised Geneva Score (age, previous PE/DVT, surgery/lower limb or fracture in the past month, having active malignancy, unilateral lower limb pain, hemoptysis, Heart rate, and pain on limb palpation).19 The score was calculated after reviewing each patient file including the physician notes and the flow chart of the vital signs. There was no specific form for the RGS in our system.
Acute PE refers to obstruction of the pulmonary artery or one of its branches by material (eg, thrombus, tumor, air, or fat) that originated elsewhere in the body. The diagnosis was based upon a CT angiogram report from the radiology department confirming that a thrombus was the main cause of the obstruction. A value of D-dimer above 500 FEU (0.5µg/mL) was considered the cutoff value above which imaging modality was mandated. Age-adjusted D-Dimer threshold was calculated by multiplying the age of the patient 50 years and above by 10 [Age-adjusted D-dimer (FEU) =Patient’s age x10) or [Age-adjusted D-dimer (µg/mL) = (Patient’s age x10)/1000]. The manufacturer of the D-dimer test at our facility is SIEMENS [Instrument: Sysmex CS-2000i/CS-2100i Systems].
Data were entered and analyzed using SPSS software version 26. Quantitative variables were expressed as means and standard deviation. Categorical values were expressed as frequencies and percentages. Sensitivity, Specificity, NPV, and PPV were calculated for the diagnostic test results. The level of agreement between conventional and age-adjusted D-dimer was calculated with kappa. Estimation of the amount of unnecessary radiation exposure was done by calculation of the percentage of patients with positive age-adjusted D-Dimer and did not have PE by CTPA. Receiver Operator Characteristic curve was applied to allocate the optimum RGS cutoff for the exclusion of PE. Significance was considered at a p-value of <0.05.
Of 2010 patients with an average age of 52.2±20.2 years, two-thirds (65.1%) were females, with the previous history of; DVT or PE (2%), surgery and/or fracture of lower limb (6.9%), active malignant conditions (14.4%), unilateral lower limb pain (0.6%), and hemoptysis (0.7%) (Table 1). A total of 332 (16.5%) patients were diagnosed as PE patients by CTPA. The sensitivity of conventional D-dimer for PE was high (94%), with only 20 false negatives (1.0%), decreasing slightly to 92.8% with age-adjusted D-dimer testing, with 24 (1.2%) false negatives. The specificity of D-dimer for PE was low by the conventional threshold (12.3%), increasing to 15.3% by the age-adjusted threshold, Table 2. False-negative rates were 1.0% and 1.2% for the conventional and age-adjusted thresholds, respectively.
Table 1 Personal and Clinical Characteristics of the Study Sample
Table 2 Comparison Between Conventional D-Dimer and Age-Adjusted D-Dimer in Accuracy of Prediction of Pulmonary Embolism
The level of agreement between conventional D-dimer and age-adjusted D-dimer testing in prediction of PE was high [(976+98)/1128) x 100=95.2%, kappa=0.081, p<0.001]. Both thresholds agree on 100% [(8+90)/(8+90)] of negative cases, and 97.3% [(181+795)/(185+845)] of positive cases. Agreement in Positive CTPA is 95.5% [(181+8)/198], and agreement in negative CTPA is 94.7% [(795+90)/935]. In total, 98 patients had a D-dimer below the conventional threshold of 0.5Un, and 8 PE patients of them (8.2%) were missed. Meanwhile, 152 patients had a D-dimer below the age-adjusted threshold, 12 PE patients were missed (7.9%), Table 3.
Table 3 Performance of D-dimer and Age-Adjusted D-dimer Testing and Their Level of Agreement in the Prediction of Pulmonary Embolism
According to the RGS, 747 patients (37.2%) had a low clinical probability, 1254 (62.4%) an intermediate clinical probability, and 9 (0.4%) a high clinical probability (Table 3). The prevalence of PE was 0%, 25.8%, and 88.9% in these three different probability groups, respectively, Table 4. The receiver operating characteristic curve was applied for the allocation of an optimum RGS cut-off for the prediction of PE (Figure 1). The cutoff ≥5 points was the optimum RGS cut-off for prediction of PE, with 100% sensitivity, 61.7% specificity, 34.1% PPV, and 100% NPV, and an area under the curve of 0.87, Table 4.
Table 4 Prevalence of Pulmonary Embolism in Patients with Different Revised Geneva Score Categories and Validity of a Cutoff of 5 Revised Geneva Score ≥5 in the Prediction of Pulmonary Embolism
PE could have been ruled out for more than one-half (51.5%) of all suspected cases (870 + 166= 1036) if they had used the Geneva score alone, Table 5.
Table 5 Application of a Clinical Decision Rule and Age-Adjusted D-dimer Threshold for Prediction of PE
In this study, the prevalence of PE was 16.5% among patients with suspected PE. This prevalence was comparable with an incidence of 16% in a previous study by Klok et al,20 and it ranged from 10.1% to 20.7% in other studies.13,21,22 Clinical assessment of the probability of PE is important in the diagnostic approach of PE. Applying a clinical decision rule in combination with the age-adjusted D-dimer threshold would have raised the number of patients in whom PE could have been ruled out without further imaging. According to the RGS, 747 patients (37.2%) had a low clinical probability, 1254 (62.4%) an intermediate clinical probability, and 9 (0.4%) a high clinical probability (Table 3). The prevalence of PE was 16.5%, 0%, 25.8%, and 88.9% in these three different probability groups, respectively. The corresponding prevalence figures were; 9%, 30%, and 68% as reported in the Postoperative Investigation of Pulmonary Embolism Diagnosis (PIOPED) study,23 and 8.3% 22.8%, and 71.4% as reported by Klok et al20 who concluded that PE could be excluded in patients with a low or intermediate clinical probability by RGS and a normal D-dimer level. However, from the results of our study, it may be safe to exclude PE in patients by a low clinical probability by the revised Geneva score irrespective of D-dimer results.
ROC curve was applied to allocate the optimum RGS cutoff for PE exclusion. It showed the cutoff of >5 points was the optimum RGS cutoff for prediction of PE, with 100% sensitivity, 61.7% specificity, 34.1% PPV and 100% NPV, and an area under the curve of 0.87. Douma et al24 have validated the RGS two category scale of ≤5 and >5, on 807 patients with suspected PE and found only 1 PE among 185 patients who were PE unlikely and had a normal dimer. According to the findings of our study, at this cutoff <5, PE could have been excluded even with an abnormal age-adjusted D-dimer threshold, with no missed PE cases. This would have saved the cost of 1036 (51.5%) of all CTPAs. Of 1730 patients whose age-adjusted D-dimer threshold was abnormal, only 860 patients (50%) could have been tested by CTPA, while for the remaining 870 (50.2%) cases whose clinical probability was unlikely, PE could have been ruled out without further imaging. This finding was in agreement with the finding of a previous study that reported that using the RGS and a rule-out cut point of ≤5, 62 patients of 102 patients (60.8%) would have been spared CTPA at a cost of no PEs missed.15
Our study showed that both the conventional and age-adjusted thresholds had high sensitivity and low specificity, with a slightly increased specificity from 12.3% by conventional threshold to 15.3% by the age-adjusted threshold. This finding is in agreement with the findings of a retrospective study in Scotland,15 which reported an increased specificity from 11% to 24.9%. In the present study, among patients aged 50 years or more, 8 and 12 PE patients were missed, as false negatives, by the conventional and the age-adjusted thresholds, respectively. False-negative rates ranged from 0.0 to 0.6% using a conventional threshold, and 0.2–0.8% using an age-adjusted threshold.13,21,22 In our study, the corresponding rates were 1.0% and 1.2% for conventional and age-adjusted thresholds, respectively.
This study has some limitations. This study is based on data from one tertiary hospital in Saudi Arabia, and this may not allow for the generalization of the conclusion. Moreover, it is a retrospective study from patients’ records and may make it liable to some information biases. Large-scale prospective studies, targeting the whole Saudi Arabia may be necessary.
The findings of this study confirm the fact that applying a clinical decision rule in combination with an age-adjusted D-dimer threshold would have increased the number of patients in whom PE could have been spared CTPA. PE would have been ruled out for more than one-half of all suspected cases if the Geneva score alone had been used. All those patients would have been spared CTPA with no cost of PEs missed. It may be safe to withhold oral anticoagulation therapy in patients with suspected PE, if RGS is low according to the 3 risk category scale, or unlikely (<5 points) according to the 2 risk category scale.
Data Sharing Statement
Most of the data supporting our findings is contained within the manuscript, and all others, excluding identifying/confidential patient data should, will be shared upon request.
Ethics Approval and Consent to Participate
This study was approved by the institutional review board of the MNG-HA in Riyadh, Saudi Arabia (RC19/020/R). There was no need for consenting by patients as the study was done by retrieving data from medical records with no personal identifiers, and waiving of consent was approved by the IRB committee. This study was conducted in accordance with the Declaration of Helsinki.
This study was initiated by King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. The final draft of the manuscript was English language edited by Macmillan Science Communication.
All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; took part in drafting the article or revising it critically for important intellectual content; agreed to submit to the current journal; gave final approval of the version to be published; and agree to be accountable for all aspects of the work.
The authors declare that they have no competing interests.
1. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010;363(3):266–274. doi:10.1056/NEJMra0907731
2. Al-Hameed FM, Al-Dorzi HM, Al-Momen AM, et al. The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism: outpatient versus inpatient management. Saudi Med J. 2015;36(8):1004.
3. Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. In: The Vein Book. Academic Press; 2007:323–330.
4. Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129.
5. Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360.
6. Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144(3):165–171.
7. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83(03):416–420.
8. Chong LY, Fenu E, Stansby G, Hodgkinson S. Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance. BMJ. 2012;344:e3979.
9. Righini M, Goehring C, Bounameaux H, Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med. 2000;109(5):357–361.
10. Rumley A, Emberson JR, Wannamethee SG, Lennon L, Whincup PH, Lowe GD. Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60–79 years. J Thromb Haemost. 2006;4(5):982–987. doi:10.1111/j.1538-7836.2006.01889.x
11. Penaloza A, Kline J, Verschuren F, et al. European and American suspected and confirmed pulmonary embolism populations: comparison and analysis. J Thromb Haemost. 2012;10(3):375–381.
12. Wiener RS, Ouellette DR, Diamond E, et al. An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine. Chest. 2014;145(6):1383–1391.
13. Douma RA, Le Gal G, Söhne M, et al. Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. BMJ. 2010;340(mar30 3):c1475. doi:10.1136/bmj.c1475
14. Fuchs E, Asakly S, Karban A, Tzoran I. Age-adjusted cutoff d-dimer level to rule out acute pulmonary embolism: a validation cohort study. Am J Med. 2016;129(8):872–878. doi:10.1016/j.amjmed.2016.02.043
15. Nobes J, Messow CM, Khan M, Hrobar P, Age-adjusted IC. D-dimer excludes pulmonary embolism and reduces unnecessary radiation exposure in older adults: retrospective study. Postgrad Med J. 2017;93(1101):420–424.
16. Jaconelli T, Eragat M, Crane S. Can an age-adjusted D-dimer level be adopted in managing venous thromboembolism in the emergency department? A retrospective cohort study. Eur J Emerg Med. 2018;25(4):288–294. doi:10.1097/MEJ.0000000000000448
17. Stein CE, Keijsers CJ, Bootsma JE, Schouten HJ. Missed diagnosis of pulmonary embolism with age-adjusted d-dimer cut-off value. Age Ageing. 2016;45(6):910–911.
18. Lapner ST, Stevens SM, Woller SC, Snow G, Kearon C. Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism. Thromb Res. 2018;167:15–19. doi:10.1016/j.thromres.2018.05.003
19. Ten Cate‐Hoek AJ, Prins MH. Management studies using a combination of D‐dimer test result and clinical probability to rule out venous thromboembolism: a systematic review. J Thromb Haemost. 2005;3(11):2465–2470.
20. Klok FA, Kruisman E, Spaan J, et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost. 2008;6(1):40–44.
21. Penaloza A, Roy PM, Kline J, et al. Performance of age‐adjusted D‐dimer cut‐off to rule out pulmonary embolism. J Thromb Haemost. 2012;10(7):1291–1296.
22. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117–1124.
23. Pioped Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990;263(20):2753.
24. Douma RA, Mos IC, Erkens PM, et al. Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med. 2011;154(11):709–718.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.